These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22895358)

  • 1. Are there still healthy obese patients?
    Blüher M
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):341-6. PubMed ID: 22895358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals.
    Blüher M
    Curr Opin Lipidol; 2010 Feb; 21(1):38-43. PubMed ID: 19915462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predisposition - obesity phenotype].
    Blüher M
    Dtsch Med Wochenschr; 2014 May; 139(21):1116-20. PubMed ID: 24823981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women.
    Peppa M; Koliaki C; Papaefstathiou A; Garoflos E; Katsilambros N; Raptis SA; Hadjidakis DI; Dimitriadis GD
    Obesity (Silver Spring); 2013 Sep; 21(9):1807-14. PubMed ID: 23696298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolically healthy obese individuals -- mechanisms and clinical relevance.
    Hrasko T; Bendlová B; Hainer V; Haluzík M
    Cesk Fysiol; 2016 Oct; 65(1):38-46. PubMed ID: 29489091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome.
    Müller MJ; Lagerpusch M; Enderle J; Schautz B; Heller M; Bosy-Westphal A
    Obes Rev; 2012 Dec; 13 Suppl 2():6-13. PubMed ID: 23107255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy obesity.
    Wildman RP
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):438-43. PubMed ID: 19474713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
    Klein S; Fontana L; Young VL; Coggan AR; Kilo C; Patterson BW; Mohammed BS
    N Engl J Med; 2004 Jun; 350(25):2549-57. PubMed ID: 15201411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolically healthy but obese individuals: relationship with hepatic enzymes.
    Messier V; Karelis AD; Robillard ME; Bellefeuille P; Brochu M; Lavoie JM; Rabasa-Lhoret R
    Metabolism; 2010 Jan; 59(1):20-4. PubMed ID: 19709695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women.
    Messier V; Karelis AD; Prud'homme D; Primeau V; Brochu M; Rabasa-Lhoret R
    Obesity (Silver Spring); 2010 May; 18(5):911-7. PubMed ID: 19851302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the profile of obese patients who are metabolically healthy.
    Primeau V; Coderre L; Karelis AD; Brochu M; Lavoie ME; Messier V; Sladek R; Rabasa-Lhoret R
    Int J Obes (Lond); 2011 Jul; 35(7):971-81. PubMed ID: 20975726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.
    Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P
    Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue inflammation and insulin resistance: all obese humans are not created equal.
    Gauthier MS; Ruderman NB
    Biochem J; 2010 Sep; 430(2):e1-4. PubMed ID: 20704568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic fat content is a determinant of metabolic phenotypes and increased carotid intima-media thickness in obese adults.
    Zhang H; Ma Z; Pan L; Xu Y; Shao J; Huang Z; Chen Z; Sun Q; Liu C; Lin M; Yang S; Li X
    Sci Rep; 2016 Feb; 6():21894. PubMed ID: 26902311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.